Sector consensus Arecor Therapeutics plc

Equities

Market Closed - London S.E. Other stock markets 16:35:26 13/09/2024 BST			5-day change	1st Jan Change
80.00 ^GBX	0.00%		-1.84%	-56.16%

09-11	Arecor Therapeutics plc Presents Positive Data from Phase I Clinical Trial of Ultra-Concentrated, Ultra-Rapid Acting Insulins	CI
07-23	Arecor Therapeutics Completes Retail Offer	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m Revision of opinion	Average Target P.	Ecart obj. / dr	Nbr of analysts
ARECOR THERAPEUTICS PLC		3.455	+331.88%	2
LONZA GROUP AG		624.14	+12.50%	21
IQVIA HOLDINGS INC.		276.53	+15.85%	21
ALNYLAM PHARMACEUTICALS, INC.		283.17	+6.75%	27
CELLTRION, INC.		248,000.00	+27.05%	19
MODERNA, INC.		99.84	+46.22%	19
ICON PUBLIC LIMITED COMPANY		365.40	+21.80%	15
UNITED THERAPEUTICS CORPORATION		350.71	+3.42%	13
BIO-TECHNE CORPORATION		82.55	+10.56%	13
MEDPACE HOLDINGS, INC.		406.91	+15.71%	9
QIAGEN N.V.		50.97	+9.95%	17
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		224.07	+12.82%	17
TEMPUS AI, INC		46.00	-6.84%	8
REVOLUTION MEDICINES, INC.		59.21	+35.50%	14
BACHEM HOLDING AG		82.83	+9.50%	6
IONIS PHARMACEUTICALS, INC.		62.67	+48.54%	25
BLUEPRINT MEDICINES CORPORATION	-	127.35	+43.25%	17
HANGZHOU TIGERMED CONSULTING CO., LTD		69.52	+41.91%	16
PHARMARON BEIJING CO., LTD.		22.63	+8.86%	12
Average		13,223.05	+36.59%	15
Weighted average by Cap.		24,618.14	+18.75%	18